Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
- NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
- NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_assertion evidence source_evidence_literature NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
- NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_assertion SIO_000772 21720365 NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
- NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_assertion wasDerivedFrom befree-20140225 NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
- NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_assertion wasGeneratedBy ECO_0000203 NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.